These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Susceptibility of recently isolated bacteria to amikacin in vitro: comparisons with four other aminoglycoside antibiotics. Finland M, Garner C, Wilcox C, Sabath LD. J Infect Dis; 1976 Nov; 134 SUPPL():S297-307. PubMed ID: 825588 [Abstract] [Full Text] [Related]
26. Gentamicin and amikacin---an in vitro comparison using 1000 clinical isolates. Forgan-Smith WR, McSweeney RJ. Aust N Z J Med; 1978 Aug; 8(4):383-6. PubMed ID: 282852 [Abstract] [Full Text] [Related]
29. Amikacin therapy for serious gram-negative infection. Pollock AA, Berger SA, Richmond AS, Simberkoff MS, Rahal JJ. JAMA; 1977 Feb 07; 237(6):562-4. PubMed ID: 576282 [Abstract] [Full Text] [Related]
30. In vitro evaluation of ceftazidime (GR 20263), amikacin and sisomicin, in a model simulating serum pharmacokinetics of therapeutic doses. Xerri L, Orsolini P, Broggio R. Chemioterapia; 1984 Oct 07; 3(5):271-7. PubMed ID: 6398124 [Abstract] [Full Text] [Related]